SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: J. Nelson who wrote (4364)8/26/1999 10:48:00 PM
From: Shadow  Read Replies (3) of 4650
 
It gets worse

Here is the link

ragingbull.com

Here is the text

Wow, how is that for an instant reply from Stockreporter:
I will now fax this info to Tom!! I have to "digest" it myself, but I wanted the THREAD to see the rapid response.
The obvious impediment that comes to mind, however, is the $6,100 reimbursement requirement. This seems to me to be prohibitive. Thus we will proceed with caution and perhaps even a bit of negotiation. The ultimate decision is Tom's.
Thanking you again for the "tip," here is their response:

Subj: Re: eConnect
Date: 8/24/99 12:56:55 PM Pacific Daylight Time
From: TOPRO 2000
To: EVavolizza

Dear Emanuel,

Thank you very much for your email. We are definetly interested in co-operating with you and in editing a stong buy recommendation for eConnect. As you might know the Stockreporter.de (www.stockreporter.de) specializes in the coverage of Small and Micro Caps and undervalued OTC and Bulletin Board companies and is going to be the number one Micro Caps and OTC:BB site in Europe and especially in Germany. Furthermore we are going to be one of the major sites also in the U.S. with currently 80% of our readers comming from North America. The site is completely available in both languages, German and English.

And as I said, in this context we would appreciate to co-operate with you. Regarding the information we already reviewed we are sure that your company in terms of the market capitalization will be undervalued. If we could initiate coverage for your company we could offer that you will receive a professional and comprehensive report including a strong buy recommendation with a target price that will show a very promising share price potential for your undervalued share.

After our initial report we will cover your company with regular updates for at least three month to ensure a consequent development of the share price. In this connection we would like to give you the infomation that all of our recent recommendations experienced such a massive share price increase and that their shares started to receive the exposure they deserve. Also our next recommendations are going to be great and successful reports available in the next couple of days.

So, please, consider also this aspect: All buy recommendations of our successful Stockreporter team have shown -without any exception - an extraordinary share price performance and trading volume development since Stockreporter has issued its recommendations for the respective company. Thus the portfolio of Stockreporter is a very successful and very reliable one. So the clear success of all our buy recommendations is of a big importance to us and speaks for the quality of the companies recommended by us. The following examples should proof the clear tendency of all of our recommendations:

FLNK:
- recommended at: $5
- high since recommendation: $9.5
- currently: $6.25

TLTG:
- recommended at: $4
- high since recommendation: $16.25
- currently: $10.25

CAOP:
- recommended at: $3
- high since recommendation: $3.75
- currently: $3.625

WCLT:
- recommended at: $1.1
- high since recommendation: $1.5
- currently: $1.5

We do not expect any direct compensation or fess for our recommendations and intensive coverage service. But to cover our costs we need a basic reimbursement of our costs which is supposed to amount to $6,000 per month. Usually we appreciate a minimum time for the coverage of three months to ensure a really constant price increase of the your shares. In this time we will provide the company with a buy recommendation, frequent updates and follow-ups and interviews with the CEO and other management memebers released from Stockreporter.de via both our web site and Business Wire. The reimbursement of our costs could also be payable in shares and would amount to a total of $18,000 for three months of intensive coverage.

Just to discuss the level of costs we are going to have let me explain the following: One press release of approximately 7 pages costs -as you might know- approximately $800 Business Wire fees plus another $700 translation and proof-reading services. As we expect to release 2 press releases for your company per month in the next three month this will amount to press release costs of $3,000 per month. Together with the additional costs e.g. for editing and hosting of the reports on our web site the total costs will amount to $5,000 per month which could be reimbursed for a three months engagement as we described above.

In this context I would appreciate it very much if you could contact me either by email or by phone to discuss your potential interest and the next steps. If you might already have a company brochure and other interesting information which might be useful for a comprehensive report in addition to your web site, please, do not hesitate to email theses files to me. For further questions you can call me any time. My direct phone number is: +49-172-4031383. Thank you very much!

Best regards,
Torsten Prochnow
(Chairman and CEO)

STOCKREPORTER

(Voluntary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext